Should Tyrosine Kinase Inhibitors Be Considered for...

Clinical Lung Cancer 2015 / 05 Vol. 16; Iss. 3

Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials

Vale, Claire L., Burdett, Sarah, Fisher, David J., Navani, Neal, Parmar, Mahesh K.B., Copas, Andrew J., Tierney, Jayne F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2014.11.007
Date:
May, 2015
File:
PDF, 724 KB
english, 2015
Conversion to is in progress
Conversion to is failed